288 related articles for article (PubMed ID: 37038497)
1. Absence of self-reported neuropsychiatric and somatic symptoms after Omicron variant SARS-CoV-2 breakthrough infections.
Woo MS; Mayer C; Brehm TT; Andersen G; Weigel A; Löwe B; Lohse AW; Addo MM; Gerloff C; Knobloch JKM; Schulze Zur Wiesch J; Friese MA
Brain Commun; 2023; 5(2):fcad092. PubMed ID: 37038497
[TBL] [Abstract][Full Text] [Related]
2. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
[TBL] [Abstract][Full Text] [Related]
3. Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study.
Kahlert CR; Strahm C; Güsewell S; Cusini A; Brucher A; Goppel S; Möller E; Möller JC; Ortner M; Ruetti M; Stocker R; Vuichard-Gysin D; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Vernazza P; Kuster SP; Kohler P;
Clin Infect Dis; 2023 Jul; 77(2):194-202. PubMed ID: 36905145
[TBL] [Abstract][Full Text] [Related]
4. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
7. Urticaria after breakthrough Omicron BA.5.1 severe acute respiratory syndrome coronavirus 2 infection in a triple-vaccinated (Pfizer) patient: a case report.
Ciuoderis K; Perez L; Alvarez C; Usuga J; Carvajal L; Cardona A; Maya MA; Cloherty G; Hernandez-Ortiz JP; Osorio JE
J Med Case Rep; 2023 May; 17(1):177. PubMed ID: 37138300
[TBL] [Abstract][Full Text] [Related]
8. Severe acute respiratory syndrome coronavirus 2 vaccine breakthrough infections: A single metro-based testing network experience.
Strickler SS; Esper A; Wells L; Wood A; Frediani JK; Nehl E; Waggoner JJ; Rebolledo PA; Levy JM; Figueroa J; Ramachandra T; Lam W; Martin GS
Front Med (Lausanne); 2022; 9():1031083. PubMed ID: 36507539
[TBL] [Abstract][Full Text] [Related]
9. Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
Gottlieb M; Wang RC; Yu H; Spatz ES; Montoy JCC; Rodriguez RM; Chang AM; Elmore JG; Hannikainen PA; Hill M; Huebinger RM; Idris AH; Lin Z; Koo K; McDonald S; O'Laughlin KN; Plumb ID; Santangelo M; Saydah S; Willis M; Wisk LE; Venkatesh A; Stephens KA; Weinstein RA;
Clin Infect Dis; 2023 Jun; 76(11):1930-1941. PubMed ID: 36705268
[TBL] [Abstract][Full Text] [Related]
10. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
Bergwerk M; Gonen T; Lustig Y; Amit S; Lipsitch M; Cohen C; Mandelboim M; Levin EG; Rubin C; Indenbaum V; Tal I; Zavitan M; Zuckerman N; Bar-Chaim A; Kreiss Y; Regev-Yochay G
N Engl J Med; 2021 Oct; 385(16):1474-1484. PubMed ID: 34320281
[TBL] [Abstract][Full Text] [Related]
11. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
medRxiv; 2022 Jan; ():. PubMed ID: 35118480
[TBL] [Abstract][Full Text] [Related]
12. Identification of severe acute respiratory syndrome coronavirus 2 breakthrough infections by anti-nucleocapsid antibody among fully vaccinated non-healthcare workers during the transition from the delta to omicron wave.
Dai YC; Lin YC; Ching LL; Tseng AC; Qin Y; Nerurkar VR; Wang WK
Front Med (Lausanne); 2022; 9():1019490. PubMed ID: 36523785
[TBL] [Abstract][Full Text] [Related]
13. [Short-term persistent symptoms in preschool children with mild/common coronavirus disease 2019 caused by Omicron variant infection after discharge: a follow-up study].
Hu CC; Xu P; Xu L; Zhang Y; Zhou JG; Wang LB; Zhou WH; Ye L; Lu CM
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Dec; 24(12):1289-1294. PubMed ID: 36544405
[TBL] [Abstract][Full Text] [Related]
14. Omicron infections profile and vaccination status among 1881 liver transplant recipients: a multi-centre retrospective cohort.
Ma E; Ai J; Zhang Y; Zheng J; Gao X; Xu J; Yin H; Fu Z; Xing H; Li L; Sun L; Huang H; Zhang Q; Xu L; Jin Y; Chen R; Lv G; Zhu Z; Zhang W; Wang Z
Emerg Microbes Infect; 2022 Dec; 11(1):2636-2644. PubMed ID: 36227753
[No Abstract] [Full Text] [Related]
15. Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study.
Wan J; Cazer CL; Clarkberg ME; Henderson SG; Lee SE; Meredith GR; Osman M; Shmoys DB; Frazier PI
PLoS Med; 2023 Jan; 20(1):e1004153. PubMed ID: 36626376
[TBL] [Abstract][Full Text] [Related]
16. Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.
Miyamoto S; Arashiro T; Adachi Y; Moriyama S; Kinoshita H; Kanno T; Saito S; Katano H; Iida S; Ainai A; Kotaki R; Yamada S; Kuroda Y; Yamamoto T; Ishijima K; Park ES; Inoue Y; Kaku Y; Tobiume M; Iwata-Yoshikawa N; Shiwa-Sudo N; Tokunaga K; Ozono S; Hemmi T; Ueno A; Kishida N; Watanabe S; Nojima K; Seki Y; Mizukami T; Hasegawa H; Ebihara H; Maeda K; Fukushi S; Takahashi Y; Suzuki T
Med; 2022 Apr; 3(4):249-261.e4. PubMed ID: 35261995
[TBL] [Abstract][Full Text] [Related]
17. Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks.
Bender WR; Hirshberg A; Coutifaris P; Acker AL; Srinivas SK
Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100226. PubMed ID: 32954248
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron.
Suntronwong N; Yorsaeng R; Puenpa J; Auphimai C; Thongmee T; Vichaiwattana P; Kanokudom S; Duangchinda T; Chantima W; Pakchotanon P; Assawakosri S; Nilyanimit P; Klinfueng S; Wongsrisang L; Srimuan D; Thatsanatorn T; Sudhinaraset N; Wanlapakorn N; Poovorawan Y
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335023
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin G.
Anderson M; Stec M; Gosha A; Mohammad T; Boler M; Tojo Suarez R; Behun D; Landay A; Cloherty G; Moy J
J Infect Dis; 2022 Nov; 226(11):1934-1942. PubMed ID: 36263799
[TBL] [Abstract][Full Text] [Related]
20. Specific sequelae symptoms of COVID-19 of Omicron variant in comparison with non-COVID-19 patients: a retrospective cohort study in Japan.
Omori T; Hanafusa M; Kondo N; Miyazaki Y; Okada S; Fujiwara T; Kuramochi J
J Thorac Dis; 2024 May; 16(5):3170-3180. PubMed ID: 38883639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
